191 related articles for article (PubMed ID: 412589)
1. Distribution and metabolism of prednisone in mice, dogs, and monkeys.
El Dareer SM; Struck RF; White VM; Mellett LB; Hill DL
Cancer Treat Rep; 1977 Oct; 61(7):1279-89. PubMed ID: 412589
[TBL] [Abstract][Full Text] [Related]
2. Distribution and metabolism of vincristine in mice, rats, dogs, and monkeys.
El Dareer SM; White VM; Chen FP; Mellet LB; Hill DL
Cancer Treat Rep; 1977 Oct; 61(7):1269-77. PubMed ID: 412588
[TBL] [Abstract][Full Text] [Related]
3. Disposition of 5-methyltetrahydrohomofolate in mice, dogs, and monkeys.
El Dareer SM; Tillery KF; Hill DL
Cancer Treat Rep; 1979 Feb; 63(2):201-7. PubMed ID: 109197
[TBL] [Abstract][Full Text] [Related]
4. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.
Yakatan GJ; Maness DD; Scholler J; Johnston JT; Novick WJ; Doluisio JT
Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):465-82. PubMed ID: 109903
[TBL] [Abstract][Full Text] [Related]
5. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine in mice, dogs, and monkeys.
El Dareer SM; Struck RF; Tillery KF; Rose LM; Brockman RW; Montgomery JA; Hill DL
Drug Metab Dispos; 1980; 8(2):60-3. PubMed ID: 6103788
[TBL] [Abstract][Full Text] [Related]
6. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.
Noker PE; Duncan GF; El Dareer SM; Hill DL
Cancer Treat Rep; 1983 May; 67(5):445-56. PubMed ID: 6189605
[TBL] [Abstract][Full Text] [Related]
7. Distribution of tetrahydrouridine in experimental animals.
el-Dareer SM; White V; Chen FP; Mellett LB; Hill DL
Cancer Treat Rep; 1976 Nov; 60(11):1627-31. PubMed ID: 828522
[TBL] [Abstract][Full Text] [Related]
8. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
9. Observations on the absorption, distribution, metabolism, and excretion of the dopamine (D2) agonist, quinelorane, in rats, mice, dogs, and monkeys.
Manzione BM; Bernstein JR; Franklin RB
Drug Metab Dispos; 1991; 19(1):54-60. PubMed ID: 1673422
[TBL] [Abstract][Full Text] [Related]
10. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of a new triazine antifolate in mice, rats, dogs, and monkeys.
Cashmore AR; Skeel RT; Makulu DR; Gralla EJ; Bertino JR
Cancer Res; 1975 Jan; 35(1):17-22. PubMed ID: 803254
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
17. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
Kelley JA; Litterst CL; Roth JS; Vistica DT; Poplack DG; Cooney DA; Nadkarni M; Balis FM; Broder S; Johns DG
Drug Metab Dispos; 1987; 15(5):595-601. PubMed ID: 2891473
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics of pramiverine in rats, dogs, and monkeys (author's transl)].
Steiner K; Diekmann HW; Garbe A; Nowak H
Arzneimittelforschung; 1976 Apr; 26(4b):717-21. PubMed ID: 821494
[TBL] [Abstract][Full Text] [Related]
19. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
Prueksaritanont T; Gorham LM; Ellis JD; Fernandez-Metzler C; Deluna P; Gehret JR; Strong KL; Hochman JH; Askew BC; Duggan ME; Gilbert JD; Lin JH; Vyas KP
Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862
[TBL] [Abstract][Full Text] [Related]
20. Distribution, elimination, and test for carcinogenicity of 2,6-dinitrotoluene after intraperitoneal and oral administration to strain a mice.
Schut HA; Loeb TR; Grimes LA; Stoner GD
J Toxicol Environ Health; 1983; 12(4-6):659-70. PubMed ID: 6668616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
